United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-532_3b668584-ca03-409b-b016-10c252899d4c
- Product NDC
- 71205-532
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160401
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE in 1 BOTTLE (71205-532-14) · 71205-532-14
- 15 CAPSULE in 1 BOTTLE (71205-532-15) · 71205-532-15
- 30 CAPSULE in 1 BOTTLE (71205-532-30) · 71205-532-30
- 60 CAPSULE in 1 BOTTLE (71205-532-60) · 71205-532-60
- 120 CAPSULE in 1 BOTTLE (71205-532-72) · 71205-532-72
- 90 CAPSULE in 1 BOTTLE (71205-532-90) · 71205-532-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →